Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,398,467 papers from all fields of science
Search
Sign In
Create Free Account
MEPH protocol
Known as:
Altretamine/Cisplatin/Etoposide/Mitomycin
, CDDP/HMM/MITO/VP-16
, MEPH
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Altretamine
Cisplatin
Hexalen
Broader (3)
Antineoplastic Combined Chemotherapy Protocols
Etoposide
Mitomycin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
1,2-Benzenedithiol and Toluene-3,4-dithiol Arsenic(III) Complexes—Synthesis, Structure, Spectroscopic Characterization and Toxicological Studies
M. Lyczko
,
K. Lyczko
,
A. Majkowska-Pilip
,
A. Bilewicz
Molecules
2019
Corpus ID: 207961896
A new group of arsenic(III) complexes with bidentate S,S-donor ligands, 1,2-benzenedithiol (Ph(SH)2) and toluene-3,4-dithiol…
Expand
2017
2017
Solution and Gas-Phase Reactivity of Me12 Fe8- and Related Cluster Ions.
Tobias Parchomyk
,
K. Koszinowski
Chemistry
2017
Corpus ID: 21899552
The cluster ion Me12 Fe8- is an unprecedented representative of organoiron species, which are of great interest because of their…
Expand
Review
2017
Review
2017
A cross-sectional emergency department survey of novel psychoactive substance prevalence.
C. Fockele
,
P. Armenian
American Journal of Emergency Medicine
2017
Corpus ID: 32883529
2013
2013
One-pot fluorination and asymmetric Michael addition promoted by recyclable fluorous organocatalysts
Wen-bin Yi
,
Zijuan Zhang
,
Xin Huang
,
A. Tanner
,
C. Cai
,
Wei Zhang
2013
Corpus ID: 98765937
A novel one-pot fluorination and asymmetric Michael addition reaction sequence promoted by recyclable fluorous bifunctional…
Expand
2011
2011
Development of intelligent quality prediction for manufacturing system
Chung-Lin Huang
,
Chung-Chi Huang
,
Y. Tsao
,
Hsin-Pu Lin
,
Cheng-Wei Liu
IEEE International Conference on Communication…
2011
Corpus ID: 16440254
The main purpose of this research is to develop an intelligent quality prediction system. We are proposing a parameter of quality…
Expand
2011
2011
Molybdenum (IV) imido silylamido and hydride complexes : stoichiometric and catalytic reactivity, mechanistic aspects of hydrosilation reactions
Andrey Y. Khalimon
2011
Corpus ID: 100744646
This thesis describes the synthesis, structural studies, and stoichiometric and catalytic reactivity of novel Mo(IV) imido…
Expand
2008
2008
Stabilization of copper(II) thiosulfonate coordination complexes through cooperative hydrogen bonding interactions.
A. J. Fischmann
,
C. Forsyth
,
L. Spiccia
Inorganic Chemistry
2008
Corpus ID: 3394008
A series of copper(II) thiosulfonate complexes have been prepared via the reaction of [Cu(Me 3tren)(OH 2)](ClO 4) 2 (Me 3tren…
Expand
2004
2004
Silylene hydride complexes of molybdenum with silicon-hydrogen interactions: neutron structure of (eta(5)-C(5)Me(5))(Me(2)PCH(2)CH(2)PMe(2))Mo(H)(SiEt(2)).
B. Mork
,
T. Tilley
,
A. Schultz
,
J. A. Cowan
Journal of the American Chemical Society
2004
Corpus ID: 25968158
Reduction of CpMoCl(4) with 3.1 equiv of Na/Hg amalgam (1.0% w/w) in the presence of 1 equiv of dmpe and 1 equiv of…
Expand
1998
1998
In vivo assessment of dental plaque pH changes in children after ingestion of snack foods.
E. Koparal
,
C. Eronat
,
N. Eronat
ASDC journal of dentistry for children
1998
Corpus ID: 19051008
The aim of this study was to investigate the effects of some snack foods on plaque pH in children. In vivo dental plaque pH…
Expand
1984
1984
Mitomycin‐C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second‐line regimen in lung cancer
A. Chahinian
,
G. Green
,
J. Holland
American Journal of Clinical Oncology
1984
Corpus ID: 7844069
FIFTY-THREE PATIENTS WITH ADVANCED LUNG CANCER refractory to chemotherapy with MACC (methotrexate, adriamycin, cyclophosphamide…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE